Skip to main content

Table 1 Anthropometric and clinical characteristics of the study population

From: Evaluation of DOK5 as a susceptibility gene for type 2 diabetes and obesity in North Indian population

Characteristics

Type 2 diabetic patients

Control subjects

N (Men/Women)

1019 (592/427)

1006 (606/400)

Age (years)

53 (45-62)

50 (44-60)

BMI (Kg/m2)

  

   Men

23.8 (22.0-26.0)

23.1 (20.1-25.7)

   Women

26.7 (24.2-29.2)

25.0 (21.1-28.5)

WHR

  

   Men

1.0 (0.97-1.03)

0.97 (0.92-1.0)

   Women

1.0 (0.97-1.03)

0.86 (0.82-0.92)

Systolic BP (mmHg)

130 (130-140)

120 (112-132)

Diastolic BP (mmHg)

80 (78-90)

80 (70-88)

HbA1c (%)

7.8 (6.5-9.4)

5.2 (4.9-5.6)

Fasting Glucose (mmoles/L)

7.9 (6.4-10.3)

4.9 (4.5-5.3)

Fasting Insulin (μU/mL)

13.8 (7.0-27.8)

5.4 (2.9-9.6)

HOMA-IR

5.2 (2.3-9.6)

1.2 (0.6-2.0)

C-peptide (ng/mL)

2.7 (1.7-4.1)

1.6 (1.1-2.2)

hsCRP (mg/L)

2.2 (0.9-4.7)

1.3 (0.6-3.0)

Total cholesterol (mg/dL)

163 (137-195)

170 (146-199)

LDL-C (mg/dL)

100 (77-130)

108 (90-132)

HDL-C (mg/dL)

40 (35-48)

41 (34-50)

TG (mg/dL)

138 (100-198)

117 (86-161)

Urea (mg/dL)

26 (20-33)

24 (19-29)

Uric acid (mg/dL)

4.9 (3.9-6.0)

4.9 (4.0-5.7)

Creatinine (mg/dL)

0.84 (0.67-1.07)

0.75 (0.66-0.88)

  1. Data are median values with interquartile ranges in parentheses.